Related Experiment Videos

Statins utilisation pattern: a retrospective evaluation in a tertiary care hospital in Thailand

Nathorn Chaiyakunapruk1, Olarik Asuphol, Teerapon Dhippayom

  • 1Center of Pharmaceutical Outcomes Research (CPOR) Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences Pharmaceutical Care Research Unit, Naresuan University Buddhachinnaraj Hospital, Phitsanulok, Thailand. nui@u.washington.edu

Insights

Many patients, especially those using statins for primary prevention, do not require this medication. New generation statins like atorvastatin are often unnecessary unless specific low-density lipoprotein cholesterol goals are needed for secondary prevention.

Area of Science:

  • Cardiology
  • Pharmacology
  • Health Services Research

Background:

  • Statin therapy is widely prescribed for cardiovascular disease prevention.
  • Understanding statin usage patterns is crucial for optimizing patient care and resource allocation.

Purpose of the Study:

  • To analyze statin prescribing patterns in a tertiary care hospital.
  • To evaluate the necessity of new-generation statins based on patient indications and lipid goals.

Main Methods:

  • Retrospective cohort study of 2479 new statin users in Thailand.
  • Indication assessment based on coronary heart disease (CHD) history and CHD-risk equivalents.
  • Analysis of lipid profiles and achievement of low-density lipoprotein cholesterol (LDL-C) goals.

Main Results:

  • 58% of statin users received them for primary prevention; all atorvastatin use in this group was deemed unnecessary.
  • For secondary prevention aiming for LDL-C <130 mg/dL, 80% of atorvastatin users could switch to simvastatin.
  • To achieve LDL-C <70 mg/dL, 58.6% of patients required atorvastatin, while 40.2% of simvastatin users met this goal.

Conclusions:

  • A significant number of patients, particularly those on primary prevention, do not need statin therapy.
  • Atorvastatin is largely unnecessary except for secondary prevention in patients needing intensive LDL-C reduction (<70 mg/dL).
  • Findings suggest a need for hospital policies to ensure appropriate statin utilization.
Abstract

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.